Stonebridge Financial Group LLC Makes New $343,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stonebridge Financial Group LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 658 shares of the medical equipment provider’s stock, valued at approximately $343,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Focus Financial Network Inc. increased its stake in Intuitive Surgical by 17.1% during the 4th quarter. Focus Financial Network Inc. now owns 1,491 shares of the medical equipment provider’s stock valued at $778,000 after purchasing an additional 218 shares in the last quarter. Summit Trail Advisors LLC grew its holdings in shares of Intuitive Surgical by 21.1% during the fourth quarter. Summit Trail Advisors LLC now owns 6,602 shares of the medical equipment provider’s stock valued at $3,446,000 after buying an additional 1,150 shares during the last quarter. Sycomore Asset Management increased its position in shares of Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares in the last quarter. Soltis Investment Advisors LLC raised its holdings in Intuitive Surgical by 12.1% in the 4th quarter. Soltis Investment Advisors LLC now owns 582 shares of the medical equipment provider’s stock worth $304,000 after acquiring an additional 63 shares during the last quarter. Finally, Silicon Valley Capital Partners bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $129,000. 83.64% of the stock is currently owned by institutional investors.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock valued at $3,587,582 over the last three months. Corporate insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on the company. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Trading Down 0.7 %

NASDAQ ISRG opened at $591.65 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market cap of $210.73 billion, a price-to-earnings ratio of 92.30, a PEG ratio of 5.67 and a beta of 1.39. The company’s 50 day moving average is $555.91 and its two-hundred day moving average is $515.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.